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Introduction: Heart rhythm disorders are associated with increased 
morbidity and mortality. However, triggers and implications in 
patients with heart transplantation are not clear.
Objectives: The purpose of this research paper is to identify and 
explain the determinants for the onset of electrical conductivity 
alterations in patients with a heart transplant, as well as to describe 
the most common arrhythmias and their pathological implications.
Materials and methods: A literature review was made in the PubMed 
online database for a total of 411 results. In addition, clinical practice 
guidelines on cardiac transplantation, cardiovascular electrophysiology 
and infective endocarditis were searched. Sixty articles related to the 
objectives of this study were chosen.
Results: Surgical technique, heart denervation, sinus node 
trauma, graft rejection, endomyocardial biopsies and infections 
are the main factors that compromise organ viability and the life of 
transplanted patients. These factors can be observed as sinus rhythm 
disturbances.
Conclusions: When a cardiac arrhythmia is detected, the medical 
team must provide a treatment that is not limited to symptomatic 
and sinus rhythm control. An active search of the etiology must be 
initiated since it may indicate an underlying pathological process. 
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Tachycardia (MeSH).
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| Resumen |
Introducción. Las alteraciones del ritmo cardíaco están asociadas 
con un aumento en la morbimortalidad; sin embargo, en pacientes con 
trasplante cardíaco no son claros sus desencadenantes ni implicaciones.
Objetivos. Realizar una búsqueda en la literatura para identificar 
y explicar los determinantes en la generación de alteraciones de la 
conducción eléctrica en pacientes con trasplante cardíaco, así como 
describir las principales arritmias que pueden presentarse, explicando 
sus implicaciones patológicas.
Materiales y métodos. Se realizó una búsqueda en la base de datos 
PubMed que arrojó un total de 411 resultados. Además, se buscaron 
las guías de práctica clínica sobre trasplante cardíaco, electrofisiología 
cardiovascular y endocarditis infecciosa. Se eligieron 60 artículos que 
lograban responder a los objetivos de este estudio.
Resultados. La técnica quirúrgica, la denervación cardíaca, las 
lesiones del nodo sinusal, el rechazo del injerto, las biopsias 
endomiocárdicas y las infecciones son los principales factores 
que comprometen la viabilidad del órgano y la vida del paciente 
trasplantado, manifestándose como alteraciones del ritmo sinusal.
Conclusiones. Ante la detección de alguna arritmia cardíaca, el 
equipo médico debe proporcionar un manejo que no se limite al 
control sintomático y del ritmo sinusal, sino que se debe iniciar una 
búsqueda activa de su etiología, ya que esta puede ser la manifestación 
de un proceso patológico subyacente.
Palabras clave: Trasplante de corazón; Arritmia cardíaca; Bradicardia; 
Taquicardia (MeSH).
Figueroa-Bohórquez DM, Benavides X, Garzón L, Espinel D, Suarez L, Uribe 
M, et al. [Alteraciones electrocardiográficas en el paciente con trasplante cardíaco. 
480 Arrhythmias after cardiac transplantation: 483-9
Desencadenantes, mecanismos y su significado]. Rev. Fac. Med. 2017;65(3):483-
9. English. doi: http://dx.doi.org/10.15446/revfacmed.v65n3.57498.
Introduction
Despite the progress in pharmacological treatment, organ transplantation 
can lead to multiple chronic pathologies that cannot be properly 
addressed with medical management (1). Cardiac transplantation is 
reserved for patients with heart disease who evolve to advanced and 
symptomatic heart failure despite optimal medical management, in 
other words, functional status D and functional class IV according to 
the New York Heart Association classification (NYHA) (2).
With the development and improvement of surgical techniques, as 
well as the improvement of post-transplant management, the patient is 
expected to restore hemodynamic stability, improve functional class 
and have a better quality of life, reaching survivor rates at 1 year and 
10 years close to 90% and 50%, respectively (2-5).
Often, survival and quality of life are compromised by the onset 
of arrhythmias at any time after transplantation, and triggers and 
implications are not clear to date. The purpose of this article is to 
conduct a literature review to identify and explain the variables 
associated with cardiac transplantation that influence alterations 
in sinus rhythm and electrical conduction, during or after surgery. 
Similarly, a description of the main arrhythmias that patients may 
suffer after orthotopic cardiac transplantation and its consequences 
is presented. 
Materials and methods
A systematic review was made in the PubMed database based on 
multiple combinations of MESH terms: “heart transplantation”, 
“Arrhythmias, Cardiac”, “Tachycardia, Ventricular”, “Tachycardia, 
Supraventricular”, “Bradycardia”, “Pacemaker, Artificial” and 
“Catheter Ablation”. The search was limited to studies in human. 
Articles that addressed heterotopic heart transplantation or that were 
written in a language other than English or Spanish were excluded. 
411 articles were obtained. 
The abstracts obtained after the search were analyzed, and those 
that coincided with the objectives of this study were selected. In 
addition, the national guidelines for cardiac transplantation and 
cardiovascular electrophysiology were consulted in the official 
website of the Colombian Society of Cardiology, while information 
on clinical practice guidelines for infective endocarditis were obtained 
from the European Society of Cardiology website. In total, 60 articles 
were chosen and used as reference for this review.
Factors associated with the development of cardiac 
arrhythmias
Surgical technique
The biauricular transplantation technique was first described by Lower 
and Shumway in the 1960s, and is characterized by myocardium 
anastomosis between both donor atria and a remnant of these 
structures in the recipient. Later, in the 1990s, the literature described 
the bicaval technique, in which anastomosis occurs in the large vessels 
in both portions of the vena cava and around the pulmonary veins, 
resulting in less manipulation and alteration of the atria (6). 
Currently, a strong discussion has taken place around which 
techniques should be preferred, since long-term results do not show 
significant differences, although multiple publications demonstrate 
the benefits of the bicaval technique with respect to the standard 
technique (3,7-11). 
The biauricular technique has demonstrated that suture lines form 
scars that act as low voltage areas, and that they isolate electrically 
the donor tissue from the receptor tissue, which is the reason for a 
higher incidence of flutter-type arrhythmias in patients who undergo 
this surgical technique. 
Furthermore, randomized controlled studies have reported that 
the use of the bicaval technique needs less pacemakers implantation; 
however, no association was established between the permanent use of 
this device and long-term survival (12- 14). Czer et al. (12) developed 
a study comparing the functional class of transplanted patients 
with both surgical techniques during physical activity, considering 
variables such as heart rate, oxygen consumption, carbon dioxide 
production and duration of exercise, without finding differences 
between both groups. 
Denervation and reinnervation
All surgical techniques involve cardiac denervation, which causes 
the heart to lose its autonomic regulation and, in consequence, the 
variability of the heart rate as a way of physiological adaptation to 
different stimuli of the environment. For this reason, the transplanted 
organ is guided by the sinus node rhythm and only responds to 
chronotropic, inotropic and dromotropic stimuli of the circulating 
catecholamines (15), and to the changes in blood volume caused 
by the venous return that stimulates a determined contraction force 
according to Frank-Starling’s law (16). 
Similarly, sympathetic reinnervation is considered unpredictable, 
disordered, often incomplete and variable among patients, leading 
to aberrant reinnervation, which may cause multiple sinus rhythm 
disorders (17-20). A study led by Uberfuhr (20) in Germany found 
that about 60% of patients with orthotopic heart transplantation had 
some degree of sympathetic reinnervation. 
Sinus node dysfunction
Sinus node dysfunction —defined as the absence of sinus rhythm, 
sinus node recovery time greater than 1.4 ms or secondary electrical 
pauses during electrophysiological examinations— is the most 
common cause of early implantation of pacemakers in transplant 
patients, that is, before 3 months after surgery (21-23). Depending 
on the series, a prevalence between 10% and 45% of early sinus 
dysfunction is reported, reaching implantation rates of up to 30% 
in this group of patients (12,24). Early sinus dysfunction is largely 
attributed to the surgical procedure, whether caused by trauma, node 
ischemia due to nodal artery injury, or prolonged ischemia times. 
Over the years, a decrease in the incidence of sinus node alterations 
has been reported, which has been attributed to the improvement of 
the surgical technique (25). 
Deleuze et al. (13) compared the results of both surgical techniques 
in the postoperative period of 81 heart transplants, finding that the 
biauricular technique showed a higher prevalence of sinus node 
dysfunction, while patients treated with the bicaval technique did 
not require implantation of a pacemaker within the first 30 days, 
although 12.5% of them did (25). AV blocks and sinus dysfunction 
three months after the procedure are, to the same extent, the main 
indication of the implantation of a permanent pacemaker. 
Recovery of sinus node function is common, particularly, when 
these changes occur rapidly after transplantation (21,26,27). Late 
sinus node dysfunction occurs three months after transplantation, 
and about 5% of patients require implantation of pacemakers for this 
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reason according to a study published by Luebbert et al. (6), who did 
not find a higher prevalence related to any surgical technique, age, 
sex or pre-transplant diagnosis. 
Rejection of the graft
About 20-30% of patients have experienced graft rejection during the 
first year after transplantation. This process is defined as the presence 
of inflammatory infiltrate in the transplanted tissue. Hence, taking 
endomyocardial biopsies is necessary for diagnosis and classification. 
Based on the results of the histological examination of the sample, it 
can be established whether there is any degree of cellular or humoral 
rejection according to the International Society for Heart and Lung 
Transplantation in 2004 (28,29). Despite the efforts and good results 
that relate findings by magnetic resonance to graft rejection cases, the 
gold standard is still histological study (30). Some series claim that 
the presence of acute graft rejection is closely related to the onset of 
cardiac arrhythmias, especially with flutter and atrial fibrillation, but this 
remains a controversial issue. Ahmari et al. (31) from the Mayo Clinic 
state that the recurrence of moderate to severe acute rejections results 
in cardiac fibrosis that compromises diastolic function and predisposes 
the development of atrial flutter, and that these markers imply poor 
prognosis in the long term. Thus, the next step should be to rule out 
acute rejection of the graft to detect de novo alterations (17,32).
Chronic graft rejection in heart transplantation refers to cardiac 
graft vasculopathy (CGV). Although this process was initially 
understood as an immune-mediated process, today it is now known 
as a multifactorial process that includes alloimmune, autoimmune 
and non-immune mediated responses (24).
The progression of intraluminal changes, which ends in the 
occlusion of the coronary macrovasculature and microvasculature 
flow, begins as a lesion and apoptosis process in the endothelial 
parenchyma that leads to the concentric proliferation of the smooth 
muscle and to the failure of the cardiac graft, creating a terrain for 
the onset of both atrial and ventricular arrhythmias (24).
The development of CGV is the most predisposing factor to 
myocardial tissue ischemia and fibrous tissue formation, and the 
one that affects survival the most; thus, it is the main cause of death 
at 3 years after transplantation, together with malignant processes 
(30). At 5 years, 30% of transplant patients suffer CGV (24,33), and 
multiple episodes of acute rejection are considered as a risk factor 
for its development. The gold standard for this pathology is coronary 
angiography, which is why it is performed routinely in these patients.
Biopsies
Biopsies are routinely performed, and in cases when the medical 
team deems them necessary to rule out acute rejection of the graft. 
This procedure is usually performed under local anesthesia, has a 
mortality rate of 0.4% (29), and is considered the gold standard for 
detecting rejection (34).
Despite being relatively safe, the main complications of biopsy are 
ventricular perforation and cardiac tamponade, atrial or ventricular 
arrhythmias, pneumothorax, tricuspid insufficiency, ventricular 
coronary fistula, transient cardiac arrest, carotid artery puncture, 
infection and venous hematoma (29,35).
For this type of procedure, the transjugular route is the first option 
for access, whereas the femoral vein route is used in case of difficulty 
with jugular access or if coronary angiography is performed during 
the procedure.
There is no consensus as to how often routine biopsies should be 
taken. The Colombian cardiac transplant guidelines of 2009 suggest 
that 11 biopsies should be taken during the first year (29), while the 
international guidelines for cardiac transplantation and lung cancer of 
2010 propose 18 biopsies during the same period of time (36). Nguyen 
et al. (37) recommend a maximum of 31 endomyocardial biopsies, 
since they demonstrated that exceeding this number of repetitions 
increases the risk of severe tricuspid insufficiency. 
Over time, progress in immunosuppressive treatment has decreased 
rejection rates, which would explain the decrease in the frequency 
of this diagnostic procedure. However, further studies are needed to 
establish a global consensus in this regard, since acute rejection is 
usually a subclinical process with severe long-term repercussions.
During the procedure, ventricular arrhythmias are common, but 
they are usually temporary and transient. In the long term, third degree 
atrioventricular (AV) blocks have been associated (27) because of the 
frequency of this procedure, although this is not widely described in 
the literature and is considered an uncommon event.
Magnetic resonance imaging is suggested to replace endomyocardial 
biopsies, obtaining promising results in preliminary studies (38,39). 
Infections
Immunosuppressive therapy opens the door to a large number of 
microorganisms that the immune system could control if it functions 
properly.  According to the type of therapy and the postoperative 
time, the etiological agents of greater incidence vary (29). About 12% 
of deaths after transplantation within the first month are associated 
with infections by nosocomial bacterial microorganisms in different 
sites. Between the second and sixth month, infectious pathologies 
are usually caused by opportunistic infections and the reactivation of 
latent infections. Finally, microorganisms acquired in the community 
are the most frequent after the sixth month (29,40). 
Estimations indicate that about 1.5% of cardiac transplant 
patients are infected with infectious endocarditis (IE), mostly by 
Staphylococcus aureus and Aspergillus fumigatus. Risk factors 
include the use of central catheters in the perioperative period and 
frequent endomyocardial biopsies (41). 
Electrical conduction disorders are observed in 1% to 15% of 
IE patients, mostly manifested as AV blocks, branch blocks and 
atrial fibrillation. The presence of these alterations is associated 
with poor prognosis and higher mortality (42). Infections caused 
by agents such as cytomegalovirus and Chlamydia pneumoniae 
favor the development of CGV and, consequently, graft failure and 
cardiac arrhythmias caused by the mechanisms described above. C. 
pneumoniae infection is associated with greater severity of CGV (24).
Drugs
The average effect of amiodarone is prolonged, so it is possible to 
continue to observe its effects for several days in patients who took 
it before the transplantation. In patients who develop early sinus 
dysfunction, the effect of amiodarone may further compromise the 
electrical conduction of the transplanted organ (17).
Arrhythmia in the transplanted patient
Tachyarrhythmias
Supraventricular tachyarrhythmias
Supraventricular tachyarrhythmias have a high incidence in 
transplanted patients, greatly compromising their quality of life and 
survival. Dahu et al. (43) proposed five mechanisms involved in 
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the development of atrial arrhythmias: 1) reentrant in the donor’s 
atrium associated with the scar or the valve; 2) focal tachycardia 
in the donor’s atrium; 3) atrial fibrillation in the donor’s atrium; 4) 
re-entry arrhythmias that compromise two or more reconnections 
between donor and recipient atrium, and 5) arrhythmias originating 
in the recipient atrium that pass to the donor through one or more 
focal reconnections. 
In turn, Vaseghi et al. (32) reviewed supraventricular tachycardia, 
and proposed another mechanism related to pre-existing alterations 
in the electrical conduction of the donor, which are manifested as 
AV nodal reentrant tachycardia and re-entry tachycardia associated 
with abnormal beam (32,44).
Supraventricular tachyarrhythmias can be classified as:
Atrial fibrillation, which is common in the early postoperative 
period and is almost always associated with graft manipulation, 
inflammatory period and autonomic changes. The incidence of atrial 
fibrillation decreases progressively, becoming exceptional during the 
late postoperative period in the absence of vasculopathy, rejection or 
infection (17,32,43,45). These low numbers are associated with the 
isolation of pulmonary veins, cava veins and the posterior wall of the 
atrium, which are the main foci of generation. This occurs because 
the surgical scar acts as an electrical insulator between recipient and 
donor atria remnants (46). 
When atrial fibrillation is identified, the first step to take should 
be discarding the clinical cases previously mentioned as possible 
triggers. The control of these pathologies may be sufficient in most 
cases to stop their development. Antiarrhythmic drugs of choice are 
amiodarone and procainamide, which are not usually formulated 
for a long time because of the high resolution rate of this type of 
cardiac arrhythmia, which is associated with the management of 
its triggers. Controlling immunosuppression levels is necessary 
due to the interaction of amiodarone and warfarin with ciclosporin 
and tacrolimus (17). In case of persistence, catheter ablation is the 
treatment of choice for this disorder (17). 
Atrial Flutter is the most common type of arrhythmia in patients 
after a heart transplant. In non-transplanted patients, the isthmus-
dependent atrial flutter is formed by a counterclockwise circuit, which 
compromises the tricuspid valve, the Thebesian valve, the opening 
of the superior and inferior vena cava, and the crista terminalis. In 
transplanted patients, a similar circuit is formed, with the difference 
that the posterior line of the latter conforms the atrial suture line 
(47). This type of arrhythmia is more common in the biauricular 
technique (48).
Mitral annular flutter is less common and has no major incidence 
on a particular type of surgical technique. Just like atrial fibrillation, 
the development of flutter is also associated with periods of acute 
rejection, infection or vasculopathy, and their identification should 
stimulate the active search of these entities in the transplanted patient. 
When these causes are discarded and treated, as well as ventricular 
dysfunction and valvular pathology, catheter ablation is recommended 
to form an electrical block line between the tricuspid ring and the atrial 
suture for the right atrial-dependent flutter (48), whereas ablation of 
the anterior line of the circuit is recommended for the left atrium (49).
Focal atrial tachycardia is caused by the formation of depolarization 
foci near the atrial scar that take control of the heart rhythm. Scars, 
together with fibrosis, predispose to the formation of areas of slow 
electrical conduction, and provide the substrate for the production of 
macroreentrants and the development of focal atrial tachycardia. Elsik 
et al. (45) reported patients in whom the focus is found in the donor’s 
atrium, while Vaseghi et al. (32) describe cases in which depolarization 
begins in the atrial remnant of the recipient and passes into the donor 
tissue through bridges formed by fibroblasts, which create gap-like 
junctions that allow electrical transmission. Definitive treatment is 
focal catheter ablation. 
Atrial reentrant and nodal reentrant tachycardia require a 
preexisting route in the donor that allows a macroreentrant. Although 
they have been described in the literature, they are uncommon in 
transplanted patients. Radiofrequency ablation is curative (32).
Ventricular tachyarrhythmias
Ventricular extrasystoles and non-sustained ventricular tachycardia 
may be common in the early post-transplant period. The subsequent 
development of sustained and non-sustained ventricular tachycardia 
suggests an episode of acute rejection or graft vasculopathy (18), 
while taking into account other rare etiologies that may have similar 
clinical features and may be reversible, such as idiopathic fascicular 
ventricular tachycardia (50). 
The most common arrest rhythm in cardiac denervation in sudden 
death events is asystole, followed by pulseless electrical activity; both 
are non-defibrillating rhythms, so the use of automatic implantable 
defibrillators remains controversial (17,51).
Bradyarrhythmias
Bradyarrhythmias may appear during the early or late period after 
a heart transplant, and can be caused by sinus node dysfunction or 
errors in the electrical conduction, with functional or dysfunctional 
sinus node.
In the early postoperative period, the transplanted heart usually 
requires positive chronotropic agents or temporary pacemaker 
implantation. It has been demonstrated that the donor’s sinus node 
is hypersensitive to these pharmacological agents, so its use must 
be cautious (52).
Early sinus node dysfunction puts the patient’s life at risk in the 
early postoperative days, and its multifactorial etiology is almost 
always associated with circumstances that depend on the surgical 
procedure (12,21,53,54). As for late sinus dysfunction, the role of 
graft rejection in its development is controversial. 
Sinus dysfunction may be paroxysmal or persistent, and may be 
manifested as sinus bradycardia or as a total stop of the sinoatrial node 
(53,54). To control these entities, a therapeutic test can be performed 
with isoprenaline, dopamine, dobutamine or theophylline in search 
of increased heart rate and recovery of sinus rhythm. If this therapy 
fails, the use of pacemakers should be considered (21,55). 
The 2011 Colombian guide to cardiovascular electrophysiology 
(56) provides the following recommendations for the implantation 
of a permanent pacemaker:
Class I: it is indicated in symptomatic, inappropriate, persistent or 
not-expected-to-improve bradycardia.
Class IIA: it is considered in symptomatic, recurrent and prolonged 
bradycardia that limits rehabilitation or discharge during the post-
surgical recovery phase of the transplant (level of evidence C).
Class IIB: it is considered in patients with syncope after cardiac 
transplantation although bradyarrhythmia has not been documented 
(level of evidence C).
Early implantation of a permanent pacemaker occurs when the 
heart rate has not been normalized with other interventions after three 
weeks (57). Early sinus dysfunction in the early postoperative period 
is usually not associated with damage to the electrical conduction 
system, so bicameral pacemakers with AAIR/DDDR function that 
seek physiological stimulation and preserve AV synchrony have been 
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widely used in the last years. However, after one year of implantation, 
the frequency of activity of these devices decreases, in most cases 
due to the recovery of the sinus function (55,57,58).
In the late postoperative period, errors in the conduction of the 
nerve impulse are predominant, with AV blocks being the leading 
cause of implantation of cardiac pacemakers in this period. This 
phenomenon has been attributed to the development of graft rejection, 
since electrical conduction tissue has been proven as a typical target 
of humoral response during this process (52,56,59).
Conclusions
The development of arrhythmias is a frequent issue and, in some 
cases, puts the life of the patient at risk. This complication is related 
to multiple triggers. There are factors associated with the surgical 
procedure itself, such as ischemia times, sinus node injury, and 
excessive manipulation of the atria due to the surgical technique 
and cardiac denervation, as well as other mechanisms related to 
the preoperative and post-surgical periods, such as acute rejection 
episodes, reinnervation, ventricular biopsies, graft vasculopathy, 
systemic infections, and drug effects.
The most common arrhythmias are bradycardia, which, in a 
significant percentage, will require implantation of permanent 
pacemakers. The most frequent tachyarrhythmia is the isthmus-
dependent flutter, which can be treated with catheter ablation. The 
most common rhythm of cardiac arrest in these patients is asystole, 
unlike the general population, where more defibrillatory rhythms 
such as tachycardia and ventricular fibrillation occur.
The detection of any cardiac arrhythmia should lead to think of the 
possibility that this is the manifestation of an underlying pathological 
process that puts at risk the viability of the organ and the life of the 
patient. The medical team is obliged manage this condition in a way 
that is not limited to symptomatic control and sinus rhythm, but to 
initiate an active search for its etiology to give optimal therapeutic 
management to each patient.
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